The first 500 patients to have sacral anterior root stimulators implanted for bladder control are described. Of 479 survivors, 424 were using their stimulators when last followed up between 3 months and 16.1 years (mean 4 years) after implantation.
Introduction
The sacral anterior root stimulator was developed by experiments on baboons in the MRC Neurological Prostheses Unit in London during the years 1969-77. The first micturition driven by a stimulator implanted into an animal was achieved in February 1972.l -3 Similar work was done several years later in San Francisco. The San Francisco group reported micturition driven by external electrical stimulator in acute experiments in dogs in 1978,� but by implant not until 1982. 5 The first human sacral anterior root stimulator was implanted in London in 1976," but gave no useful micturi tion. The second and third were implanted in 1978." They were successful, and one of them is still in use in 1994. Somewhat similar implants were developed in San Francisco a few years later. Literature on the San Francisco implants is scanty. Twenty-three of them have been reported in publica tions/'s but it seems that very few more than these 23 have been implanted. The present paper reviews the first 500 patients with implants of the London design. 6. 9-� 8 The SOOth was implanted in February 1992.
It is usual to cut the sacral posterior roots at the time of implantation of electrodes on the anterior. This practice was begun in 1981 to improve continence.1O It was not at first done in all patients, and was restricted to the S2 and S3 roots. The benefit to the upper urinary tracts of doing it in all or nearly all patients, and of including the S4 roots, was first pointed out by Dr D Sauerwein in 1986, and it was hel 7 who first achieved satisfactory posterior rhizotomy in S4, where it is more difficult than in S2 and S3.
Sources of information
The largest source of information is a questionnaire sent out in 1991 to all centres in which sacral anterior root stimulators have been implanted. The questionnaire was short, and designed to be easily answered. It asked for sex, date of birth, date of implantation, date of most recent follow up, whether the patient had died and if so the cause of death, whether the implant was in use at the most recent follow up, any possible harmful effects of use of the im plant on the upper urinary tract, whether the implant became infected, and any failures in the implant. No questions were asked about benefits of the implant, for reasons that will be considered in the discussion.
By the end of 1992 every centre had answered. I am very grateful to those who have helped me in this way. They are listed in the Appendix. Many centres have pro vided further information in 1993 and 1994, and some have kindly sent information that I did not directly request, but was very glad to have.
Some of the facts reported were learned by my talking to the patients, and examining and investigating them; I have been in volved in the clinical management of 241 of the 500 patients, and have at some time talked with all these and 43 others. The major centres of implantation are listed in Table I . During the last 13 years I have visited all the major centres except Berlin (10 of them were visited five or more times each, and three others four times each), and 22 of the 28 minor centres.
The cases reported by each centre have been compared with the sales records, classified by year and destination, provided by the manufacturers (Finetech Medical Ltd). The agreement is close enough to prove that the 500 cases here reported are very nearly the real first 500. The number accidentally omitted, and hence accidentally replaced by patients whose serial numbers should properly be just over 500, is unlikely to be as many as five. Paraplegia 
(1994) 795-805
A little information is taken from publica tions in which patients are listed and can be identified one-to-one with those given in an answer to my questionnaire. 11-13.16,18.33,34,47 From reference 44, supplementary informa tion about the Le Mans and Bordeaux patients was obtainable, even though these patients were not tabulated as individuals,
In 1992, Dr P E V van Kerrebroek sent out a much longer questionnaire than mine to the same centres, He received replies from 23 centres, but the largest German centre, the second-largest Dutch centre and all British centres except Hexham failed to reply, His analysis of the replies has been published,�o It covers 184 patients, of whom 165 come within the first 500,
The total follow up time for all 500 patients is 2033.5 years, If implants that have never been used and the final period of non-use of implants that have ceased to be used are subtracted, the figure becomes 1922.9 years. Table II shows the number of implantations in each year from 1976 to 1991. The increase year by year has been slow, but it has continued almost without interruption. Table III shows the kinds of implant used. Table IV shows what posterior rhizotomy (within the range S2-5) was attempted at the time of implantation, and whether further deafferentation was done later.
In all the 12 patients whose primary deafferentation was at the conus, and in 11 other patients, the electrodes were im planted extradurally in the sacrum. In all or most of the other 477 patients, they were implanted intrathecally at the level of the fifth lumbar vertebra and last intervertebral disc.
The patients
Tables V and VI classify the patients by age and lesion.
Of the 498 spinal cord lesions, 55 were described as incomplete and 323 as com plete. For 173 of them no statement was made about completeness. Among the 55 with lesions known to be incomplete, 25 had sparing of posterior column function only, and 30, including all the nine with multiple sclerosis, retained some pain sensitivity. In 14 of the 30 with spared pain sensitivity, four-, six-or eight-channel implants were used.
Total time of use
The aggregate follow up of the 500 patients, from the date of operation to when they were last seen or telephoned, is 2033.5 years. Subtracting all periods of non-use (including those followed by re-use), the total time of use is 1897.1 years.
Results

Benefits
This paper would be unbalanced if it said nothing about what patients gain from having a sacral anterior root stimulator and sacral posterior rhizotomy. However, since the questionnaire asked nothing about benefits, consideration of these benefits is deferred to the discussion, where relevant publications are cited for each benefit.
Infections
Four stimulators became infected (appar ently at the time of implantation) and had to be explanted completely. In one of the four patients new electrodes were later implanted extradurally, and the new stimu lator works well.
Three of these infections were acute and demanded early explantation, but in one patient the stimulator was in use for nearly 2 years before it had to be explanted.
In two patients it became evident a few weeks after the operation that there was infection around the receiver block, but it seemed that there was none elsewhere. An incision was made near the midaxillary line and the cables cut there. Then the receiver pouch was opened, and the receiver block with at least 12 cm of each cable still attached was removed. The remaining part of the implant has remained uninfected. It will doubtless be possible to fit new receiver blocks, but this had not yet been done when I last received information. In five patients a part of the receiver became exposed either by dehiscence of the wound within the first few days or by ulceration later, in circumstances where it seemed probable that the cause of the dehiscence or ulceration was not infective. These were managed in various ways. In none of the five was the whole implant lost, and in four of them it is now in use.
Ninety-five operations have been done to remedy faults in implants, as described in detail in references 46 and 49; 75 of these were repair procedures, either replacing receiver blocks or rejoining broken cables, and 20 were implantations of new extradural stimulators. Two of the repair operations were followed by infection of the new receiver block. The infected block was removed, and after a few months replaced. Both these stimulators are now in use again.
One new extradural stimulator, im planted to replace a failed intrathecal one, became infected. It was completely re moved, and another new one will probably
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'No known CNS lesion' refers to a women who is healthy except for inability to empty her bladder.
soon be put into the patient. With the four infected at primary implantation, it brings to five (1 %) the total number of stimulators lost by infection. One stimulator which never showed any sign of being infected was explanted, for reasons unknown to me.
Present state of the patients Table VII shows the status of the implant in each patient at the last known follow up.
Deaths
The causes of 16 of the 21 deaths (sex and age in brackets for each) are recorded as suicide (five: F42, F30, F42, M52, F64); multiple sclerosis (two: F40, F56); cardio vascular accident (one: F56); coronary thrombosis (one: M52); septicaemia (two: M age unknown, M22); carcinomatosis, primary in the bladder (one: M42); amyloi dosis from osteomyelitis (one: M55); carci noma of breast (one: F39); renal failure (one: M34); hepatitis (one: M55). Of the two deaths from septicaemia, one followed an operation to remove kidney stones, from which the patient already suffered before he had the stimulator implanted. For five deaths (men aged 39, 43, 50, 51 and 69) the cause was not reported to me, except that for one of them (M43) the death was said to be 'unrelated to the stimulator'. Patients who do not use their implants Table VIII shows the reasons given for non-use in the 45 patients whose implants are intact but not used.
In just one of the 28 patients with inade quate implant-driven micturition, the re sponses of the bladder to sacral root stimu lation were good, and the large residual volumes were attributed to detrusor sphincter dyssynergia. In the other 27, the defective micturition is known or believed to be due mainly to weak detrusor re sponses. In four of these 27 patients, and also in four of the 21 patients who died, the detrusor responses were good at first but deteriorated after some years. 4 6 In most of the remaining patients with weak detrusor responses, they have been weak since the 10th day after the operation or earlier, and these implants have never worked well, though some of them were used for a time.
Methods of bladder management in the patients who do not use their implants are shown in Table IX . Eleven other cases of deterioration were reported. One of these was of unilateral grade 1 ureteric reflux without upper tract dilatation. The other 10 were of upper tract dilatation seen in intravenous urography or renal ultrasound examination. In three cases this was reported to have been transient. In two cases it was still present 6 and 4 years later, without deterioration of renal func tion. In five cases the duration was not reported.
Ten of the 12 patients whose upper tracts deteriorated had incomplete deafferenta tion or none. The two who had been completely deafferented had only slight and transient deterioration.
Renal function was reported as worse in only one patient other than the one who died of renal failure. This patient's sacral anterior root stimulator was implanted, with posterior rhizotomy of S3 but not S2 or S4, in 1984. In 1985 he was admitted to a spinal injuries unit with an acute illness due to urinary infection. His creatinine clearance was found to be severely impaired (16 ml/min). He had an indwelling catheter for 7 months, and then resumed use of the implant. His creatinine clearance slowly improved, and was 49 ml/min in 1988. Renal ultrasound examination in 1990 showed small kidneys, but no hydronephrosis. In June 1994 he was using his implant for micturition and defaecation, was continent, and regarded himself as healthy.
Of the 10 patients for whom radiological but not biochemical signs of upper tract deterioration were reported, one is among the 21 listed above as having died (aged 42 from carcinomatosis, primary in the blad der). The other nine were in good health when last seen except that in one of them Paraplegia 32 (1994) 795-805 stones were found in the left kidney at the last routine radiological examination, 5� years after implantation of his stimulator. Seven of these nine patients use their implants, one has an indwelling catheter, and one does intermittent self catheter isation.
Need for secondary deafferentation
Some early patients did not have full sacral posterior rhizotomy because its benefits and practicability were not yet understood, and in a few later patients a reasoned decision was made not to do it. Table IV shows that in 25 of 143 patients with known non deafferentation or incomplete deafferen tation, a decision was later made to cut the posterior roots at the conus medullaris.
When a surgeon attempts to cut posterior roots close to the spinal cord and spare the anterior roots, he can be sure that he has done what he attempted. When he attempts the same near the root exits, he usually succeeds, but never can be quite sure that he has succeeded. Table IV shows that among 251 patients on whom complete deafferenta tion near the root exits was attempted and the surgeon was not aware at the time that he had failed to achieve it, seven neverthe less needed further deafferentation.
Discussion
Why were no questions asked about benefits?
To ask about benefits would have made the task of answering the questionnaire much more difficult. Dr van Kerrebroek's experi ence with a questionnaire that asked about benefits, and was therefore much longer than mine 40 makes it almost certain that some centres would not have answered.
There are also grounds for doubting whether statistics of benefit obtained by questionnaire would be of much value. Continence provides an illustration of the difficulty. All but three of the 96 patients in whom full sacral posterior rhizotomy was attempted and whom I know well were entirely freed from reflex incontinence as long as the bladder remained uninfected. The three exceptions all subsequently had secondary deafferentation and then became free from reflex incontinence. However, many patients whose bladders are areflexic when uninfected acquire a reflex-like incon tinence, probably depending on autonomic plexuses in the pelvis, during urinary infec tions. Should they be judged continent or incontinent? I say continent, provided that they are usually free from infection (as nearly all of them are) and free from significant stress incontinence; but the opposite opinion is legitimate. It would therefore be difficult to ensure that all centres used the same criteria of continence.
What are the benefits?
I give a list, citing those references that give information relevant to each item. Balancing benefit against risk of harm Deterioration of the upper urinary tracts has been reported in only two patients among the 365 who were or may have been fully deafferented, and in these two it was slight and transient. Among the 135 patients who were not deafferented or were incompletely deafferented there were indeed 10 with upper tract deterioration, of whom two had impaired renal function and one died of it; but this may be fewer than would have been expected if their urinary tracts had continued to be managed by the non implant methods that they were using be fore their operations. Of the 479 surviving patients, 424 were using their stimulators at last known follow up and 53 were known not to be using them. It is likely that all the 424 users were pleased with what the operation had done for them. I have never known a user who was on balance displeased, or seen any mention in the literature of such a person. What of the non-users? They are not necessarily in a worse state as a result of their operations, and many are in a clearly better state, because they are continent on intermittent self catheterisation where formerly they were incontinent. Among the first 50 patients (none of whom had complete de afferentation), six were non-users in 1986; four of these regretted having had the operation, but two did not. 1 O I can find no other published statement about satisfaction and dissatisfaction among non-users, but among the first 500 patients there are 20 fully deafferented non-users, of whom seven are personally well known to me. Five of these seven are pleased, on balance, with what the operation has done for them. The other two are displeased, but the wife of one of them (a man with multiple sclerosis) says that she regards his present continence and former incontinence as fully justifying the operation.
Does complete posterior rhizotomy of 52 to 55 always cause complete detrusor areflexia?
Reference 15 reviews some of the published evidence that the Bell-Magendie 'law' that anterior spinal roots are motor and pos terior are sensory is not exactly true, and that in many people some at least of the anterior roots contain some sensory fibres and some at least of the posterior roots contain some motor fibres. Nevertheless it seems that section of the sacral posterior roots at the conus medullaris causes com plete loss of anal skin reflex, bulbocaver nosus reflex and all reflex response of the detrusor muscle to filling the bladder and to percussion in nearly all patients. I know of only one exception, other than the very common temporary appearance of reflex like detrusor activity during urinary infec tions. The exception is a woman who had slight detrusor reflex activity at first cys tometry after posterior rhizotomy at the conus medullaris. In the following 2 years this increased and caused incontinence.
Permanence of the detrusor areflexia after 52-5 posterior rhizotomy I know of no observation contradicting the view that the detrusor areflexia following S2-5 posterior rhizotomy is permanent if it is achieved at all (as it nearly always is). Cystometrically verified detrusor areflexia after intentional posterior rhizotomy of S3 with probable unintentional posterior rhizo tomy of S4 has lasted 9 years in patient 25 of reference 21. Intentional S2-5 f,0sterior rhizotomy was not done until 1986. 7 All the four patients who had it done in that year were still areflexic at last follow up, 7, 7, 6 and 6 years later.
Whether to cut posterior roots
The benefits from cutting posterior roots are very great. If a woman with a complete spinal cord transection asks for implantation Paraplegia 32 (1994) 795-805 of a sacral anterior root stimulator without sacral posterior rhizotomy, I think she should be refused it on the ground that she has not understood the situation. Any con sent that she may have given to implantation is therefore not informed consent.
A man with a complete lesion, or a man or woman with an incomplete lesion, who makes the same request, should be deferred to a later year if the centre where the request is made has little experience. Patients with sensory sparing and men with good reflex erections have something to lose by deafferentation, so their request is not a wholly unreasonable one. It is also not irrevocable; if it later becomes clear that posterior rhizotomy should have been done, and the patient then wants it, it can be done at the conus medullaris. However, the results of the implantation of a stimulator are much less good without than with posterior rhizotomy, and in a new centre it is important that the first few implantations should be fully successful. So patients will ing to have posterior rhizotomy at the time of implantation should have priority.
Extradural versus intrathecal electrodes
The use of extradural electrodes with deaf ferentation at the ganglia is probably justi fied only when severe arachnoiditis leaves no alternativeY The use, as a primary procedure, of extradural electrodes with deafferentation at the conus medullaris is the standard practise in Barcelona 3 9 and Singapore. Its disadvantages are that the surgery involved is slightly more invasive and takes slightly longer, and that T12-L1 laminectomy is probably more risky for the stability of the vertebral column than L4-S2 laminectomy. The advantage of the Barce lona procedure is that the risk of anterior root damage is almost certainly lower. Time will tell whether it or the classical intrathecal implantation is better on balance.
